The Liver’s Warning: Biomarkers Predict Mortality in Fontan Circulation
A retrospective study of 334 adults with Fontan circulation—a palliative procedure for complex congenital heart disease—has found that non-invasive biomarkers of liver fibrosis are strong predictors of death or transplant. The research, published in *Heart*, analyzed scores including FibroSURE, APRI, FIB-4, and MELD-XI. It demonstrated that elevated scores were significantly associated with an increased hazard of adverse outcomes, with a FibroSURE score above 0.74 linked to a more than threefold increased risk. The findings suggest these readily available blood-based scores could serve as valuable prognostic tools for long-term management.
Why it might matter to you:
This research underscores the critical link between chronic systemic conditions and end-organ damage, a paradigm central to managing diabetic complications. The use of simple, non-invasive biomarkers to stratify long-term risk in a complex patient population offers a methodological parallel for improving prognostication in diabetes. It highlights a shift towards leveraging routine clinical data to predict and potentially preempt major adverse events, a strategy directly applicable to managing cohorts with diabetic nephropathy or cardiovascular disease.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
